Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

NCT03407144

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Children's Hospital of Alabama ( Site 0023) Birmingham, Alabama, United States
  • Phoenix Childrens Hospital ( Site 0034) Phoenix, Arizona, United States
  • Arkansas Children's Hospital ( Site 0046) Little Rock, Arkansas, United States
  • Kaiser - Orange County ( Site 0084) Anaheim, California, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • University Hospital Gent Ghent, Belgium
  • CH Tourelle Peltzer Verviers, Belgium
  • CHU Mont-Godinne Yvoir, Belgium
View all 22 locations
View Trial Details
Active, Not Recruiting

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

NCT03930953

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Local Institution - 109 Scottsdale, Arizona, United States
  • Local Institution - 111 Jacksonville, Florida, United States
  • Local Institution - 102 Tampa, Florida, United States
  • Local Institution - 108 Overland Park, Kansas, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

NCT03033914

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Hackensack Meridian Health Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details

Related conditions